Abstract
mHeath technologies are recognized to play important roles in the future of personal care and medicine. However, their full potentials have not been reached, as most of current technologies are restricted to monitoring physical and behavioral parameters, such as body temperature, heart rate, blood pressure, and physical movement, while direct monitoring of biomarkers in body fluids can provide much more accurate and useful information for medical diagnostics. A major barrier to realizing the full potential of mHealth is the high costs and long cycles of developing mHealth devices capable of monitoring biomarkers in body fluids. To lower the costs and shorten the developmental cycle, we have demonstrated the leveraging of the most successful portable medical monitoring device on the market, the blood glucose meter (BGM), with FDA-approved smartphone technologies that allow for wireless transmission and remote monitoring of a wide range of non-glucose targets. In this protocol, an aptamer-based assay for quantification of interferon-γ (IFN-γ) using an off-the-shelf BGM is described. In this assay, an aptamer-based target recognition system is employed. When IFN-γ binds to the aptamer, it triggers the release of a reporter enzyme, invertase, which can catalyze the conversion of sucrose (not detected by BGM) to glucose. The glucose being produced is then detected using a BGM. The system mimics a competitive enzyme-linked immunosorbent assay (ELISA), where the traditional immunoassay is replaced by an aptamer binding assay; the reporter protein is replaced by invertase, and finally the optical or fluorescence detector is replaced with widely available BGMs.
Key words
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
mHealth G. Device Listing (2012) A global list of commercially available devices in the healthcare sector, updated fortnightly 2012. http://www.gsma.com/connectedliving/wp-content/uploads/2012/04/22-November12_MobileHealth_Device_Listing.pdf
Chin CD, Cheung YK, Laksanasopin T, Modena MM, Chin SY, Sridhara AA et al (2013) Mobile device for disease diagnosis and data tracking in resource-limited settings. Clin Chem 59(4):629–640
iBG STAR, 510(k) Substantial Equivalence Determination Decision Summary (510(k) number: k103544)
iBGSTAR (2011) iBGStar® blood glucose meter. Sanofi (updated 2011; cited 2011 Dec 1) http://www.bgstar.com/web/ibgstar
Telcare (2013) Telcare (updated 2013; cited 2013 09/09) https://www.telcare.com/
Hones J, Muller P, Surridge N (2008) The technology behind glucose meters: test strips. Diabetes Technol Ther 10:S10–S26
Xiang Y, Lu Y (2011) Using personal glucose meters and functional DNA sensors to quantify a variety of analytical targets. Nature Chem 3(9):697–703, PMCID: 3299819
Xiang Y, Lu Y (2012) Using commercially available personal glucose meters for portable quantification of DNA. Anal Chem 84(4):1975–1980, PMCID: 3302979
Xiang Y, Lu Y (2012) Portable and quantitative detection of protein biomarkers and small molecular toxins using antibodies and ubiquitous personal glucose meters. Anal Chem 84(9):4174–4178, PMCID: 3341531
Nie Z, Deiss F, Liu X, Akbulut O, Whitesides GM (2010) Integration of paper-based microfluidic devices with commercial electrochemical readers. Lab Chip 10(22):3163–3169, PMCID: 3060706
Su J, Xu J, Chen Y, Xiang Y, Yuan R, Chai Y (2012) Personal glucose sensor for point-of-care early cancer diagnosis. Chem Commun (Camb) 48(55):6909–6911
Yan L, Zhu Z, Zou Y, Huang Y, Liu D, Jia S et al (2013) Target-responsive “sweet” hydrogel with glucometer readout for portable and quantitative detection of non-glucose targets. J Am Chem Soc 135(10):3748–3751
Boehm U, Klamp T, Groot M, Howard JC (1997) Cellular responses to interferon-gamma. Annu Rev Immunol 15:749–795
Liu Y, Kwa T, Revzin A (2012) Simultaneous detection of cell-secreted TNF-alpha and IFN-gamma using micropatterned aptamer-modified electrodes. Biomaterials 33(30):7347–7355
Liu Y, Yan J, Howland MC, Kwa T, Revzin A (2011) Micropatterned aptasensors for continuous monitoring of cytokine release from human leukocytes. Anal Chem 83(21):8286–8292, PMCID: 3235337
Lee PP, Ramanathan M, Hunt CA, Garovoy MR (1996) An oligonucleotide blocks interferon-gamma signal transduction. Transplantation 62(9):1297–1301
Balasubramanian V, Nguyen LT, Balasubramanian SV, Ramanathan M (1998) Interferon-gamma-inhibitory oligodeoxynucleotides alter the conformation of interferon-gamma. Mol Pharmacol 53(5):926–932
Tuleuova N, Jones CN, Yan J, Ramanculov E, Yokobayashi Y, Revzin A (2010) Development of an aptamer beacon for detection of interferon-gamma. Anal Chem 82(5):1851–1857
Stoltenburg R, Reinemann C, Strehlitz B (2007) SELEX–a (r)evolutionary method to generate high-affinity nucleic acid ligands. Biomol Eng 24(4):381–403
Wilson AB, McHugh SM, Deighton J, Ewan PW, Lachmann PJ (1993) A competitive inhibition ELISA for the quantification of human interferon-gamma. J Immunol Methods 162(2):247–255
Acevedo B, Perera Y, Ruiz M, Rojas G, Benitez J, Ayala M et al (2002) Development and validation of a quantitative ELISA for the measurement of PSA concentration. Clin Chim Acta 317(1–2):55–63
Vessella RL (1993) Trends in immunoassays of prostate-specific antigen: serum complexes and ultrasensitivity. Clin Chem 39(10):2035–2039
Matsumoto K, Konishi N, Hiasa Y, Kimura E, Takahashi Y, Shinohara K et al (1999) A highly sensitive enzyme-linked immunoassay for serum free prostate specific antigen (f-PSA). Clin Chim Acta 281(1–2):57–69
Acknowledgements
This material is based upon work supported by the US National Institutes of Health (RDA035524A and RDK100213A and ES16865) and National Science Foundation (IIP-1330934).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Lan, T., Xiang, Y., Lu, Y. (2015). Detection of Protein Biomarker Using a Blood Glucose Meter. In: Rasooly, A., Herold, K. (eds) Mobile Health Technologies. Methods in Molecular Biology, vol 1256. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2172-0_7
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2172-0_7
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2171-3
Online ISBN: 978-1-4939-2172-0
eBook Packages: Springer Protocols